KAT2A is also a critical component of a well-known stemness-associated TGF-β/SMAD signaling pathway, working downstream of TGF-β/SMAD to regulate the epithelial-to-mesenchymal transition in breast cancer [58]. Here, TGFB1 is linked to breast carcinoma.